Autopsy report · NCT01646580

Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children

“Low recruitment rate. with the final sample primary endpoint could be assessed.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 9 months after it had already started.
• Ran for about 3 years 1 month before it stopped.
• 21 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Ferrer Internacional S.A.

Sponsor type

Industry

Conditions

Dermatomycoses

Interventions

ciclopirox

Participants

21

Trials that died the same way

• Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.
  “Recruitment lower than expected and negative results.” (75% match in meaning)
• Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose
  “Low recruitment rate” (75% match in meaning)
• Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles
  “Lower than anticipated recruitment” (73% match in meaning)
• The Effect of Episiotomy on Maternal and Fetal Outcomes (EPITRIAL)
  “Slower than expected recruitment rate, and larger than expected required sample.” (73% match in meaning)
• Variable Pressure Support Trial
  “Rate of recruitment” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.